TENET HEALTHCARE CORP executive Paola M. Arbour sold common stock in an open-market transaction. On March 11, 2026, she sold 6,500 shares of Tenet Healthcare common stock at a weighted average price of $238.43 per share, with actual sale prices ranging from $238.40 to $238.68. After this sale, she directly owned 29,291 shares of Tenet Healthcare common stock.
THC filed a Form 144 reporting an intended sale of up to 6,500 shares of Common Stock through Fidelity Brokerage Services LLC. The filing shows an aggregate offering price of $1,549,773.55 and lists the broker as Fidelity Brokerage Services LLC on 03/11/2026.
The notice also lists recent Restricted Stock Vesting events: 984 shares vested on 02/28/2026 and 5,516 shares vested on 03/01/2026, both described as compensation-related. The filing does not state further proceeds treatment or other transaction details.
Tenet Healthcare’s EVP, Chief Administrative Officer and General Counsel, Thomas W. Arnst, reported selling a total of 8,000 shares of common stock in open-market transactions on March 9, 2026. He sold 4,714 shares at a weighted average price of $238.42 and 3,286 shares at a weighted average price of $239.46, in multiple trades within disclosed price ranges. Following these sales, he directly holds 12 shares of Tenet Healthcare common stock.
Tenet Healthcare Corp executive vice president of corporate development Michael T. Maloney filed an initial ownership report showing his equity holdings as of February 27, 2026. The filing lists common stock, performance stock options, and multiple tranches of time-based restricted stock units.
He directly holds common stock and performance stock options from February 2018 and February 2019, along with unvested restricted stock units granted in February 2024, February 2025, and February 2026. The restricted stock units are settled in Tenet common shares upon vesting, with vesting dates running from February 24, 2027 through February 27, 2029. The filing does not show any new purchases or sales, only existing holdings and vesting schedules.
Thomas W. Arnst filed a Form 144 reporting a sale of 24,000 common shares on 03/02/2026. The filing also lists restricted stock vesting entries labeled Compensation: 3,080 shares vested on 02/28/2026 and 4,920 shares vested on 03/01/2026.
Tenet Healthcare CEO Saumya Sutaria reported several equity compensation events involving restricted stock units and common shares. He received a grant of 36,092 2026 February restricted stock units that convert into common stock on a one-for-one basis and vest in one-third increments over three years. Previously granted RSUs from 2023 and 2024 vested, with 22,417 and 36,384 units exercised into common stock on February 27, 2026. To cover withholding taxes tied to performance and restricted stock unit vesting, he disposed of 9,282 common shares at $237.58 and 29,919 and 124,959 shares at $239.39 through tax-withholding transactions, not open-market sales. After these movements, Sutaria directly owned 658,523 shares of Tenet Healthcare common stock.
Tenet Healthcare EVP & CFO Sun Park reported equity compensation and related tax-withholding transactions. On February 27, 2026, Park received a grant of 7,520 time-based restricted stock units, which vest in one-third increments over three years and settle in common shares upon vesting.
On the same date, 4,670 restricted stock units from a 2024 award converted into an equal number of common shares. To cover withholding taxes on vested performance share units and restricted stock units, 1,626 and 1,985 common shares were withheld at prices of $237.58 and $239.39, respectively. After these transactions, Park directly held 19,438 shares of Tenet Healthcare common stock.
Tenet Healthcare EVP and CIO Paola M. Arbour reported equity compensation activity, not open‑market trading. On February 27, 2026, 1,868 restricted stock units from a February 2024 grant and 2,799 units from a March 2023 grant converted into an equal number of common shares. To cover withholding taxes upon vesting of performance and time-based restricted stock units, 499, 1,838 and 6,810 common shares were withheld at closing prices of $237.58 and $239.39 per share. After these conversions and tax-withholding dispositions, Arbour directly held 35,791 shares of Tenet Healthcare common stock.
Tenet Healthcare executive Lisa Y. Foo, EVP and Chief Operating Officer, reported several equity-related transactions in company stock. She received a grant of 7,520 restricted stock units dated 2026 February, which convert into common shares on a one-for-one basis. She also exercised 4,670 restricted stock units from a 2024 award and 4,199 units from a 2023 award, increasing her common stock holdings. To cover tax withholding obligations tied to vesting of performance and restricted stock units, 1,838 shares, 4,289 shares, and 13,706 shares of common stock were disposed of at reference prices of $237.58 and $239.39 per share, described as shares withheld for taxes rather than open-market sales. After these transactions, she directly owned 42,053 shares of Tenet Healthcare common stock.
Tenet Healthcare principal accounting officer Scott R. Ramsey reported multiple stock transactions. On March 2, 2026, he completed open-market sales totaling 8,017 shares of common stock at weighted average prices of about $230.98, $233.21, and $233.69, leaving 5,892 shares owned directly. Earlier, on February 27, 2026, restricted stock units from 2023 and 2024 grants converted one-for-one into common shares, and several transactions labeled as tax-withholding dispositions satisfied taxes due on these vestings.